Abstract | BACKGROUND: METHODS: RESULTS: Average total live adult mite counts before treatment and after four, eight and 12 weeks of spot-on moxidectin/ imidacloprid (2.5/10 mg/kg) applications were 20.1±6.3 (range, 13-33), 0.5±0.7 (range, 0-2; 6/11 were negative), 0.2±0.4 (range, 0-1; 9/11 were negative), 0.2±0.4 (range, 0-1; 9/11 were negative) and 0.1±0.3 (range, 0-1; 10/11 were negative) respectively; this difference was significant (P<0.001). Ten of 11 dogs (90.1%) achieved clinical remission, as demonstrated by the absence of demodectic mites at any life stage at monthly scrapings for eight consecutive weeks, and maintained remission throughout the 12-month follow-up period. CONCLUSION:
|
Authors | Hui-Pi Huang, Yu-Hsin Lien |
Journal | Acta veterinaria Scandinavica
(Acta Vet Scand)
Vol. 55
Pg. 40
(May 10 2013)
ISSN: 1751-0147 [Electronic] England |
PMID | 23663380
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Drug Combinations
- Imidazoles
- Insecticides
- Macrolides
- Neonicotinoids
- Nitro Compounds
- imidacloprid
- moxidectin
|
Topics |
- Administration, Topical
- Adrenocortical Hyperfunction
(complications, veterinary)
- Animals
- Dog Diseases
(drug therapy, parasitology)
- Dogs
- Drug Combinations
- Imidazoles
(administration & dosage, therapeutic use)
- Insecticides
(administration & dosage, therapeutic use)
- Macrolides
(administration & dosage, therapeutic use)
- Mite Infestations
(drug therapy, veterinary)
- Neonicotinoids
- Nitro Compounds
(administration & dosage, therapeutic use)
|